Analytical Data
-
Gene name
HOXA4
- Application
-
Alternative Names
Dfd like protein; Homeo box A4; Homeobox A4; Homeobox protein Hox-1.4; Homeobox protein Hox-1D; Homeobox protein Hox-A4; Hox 1.4 like protein; hox-1.4; hox-1d; HOX1; HOX1D; HOXA4; HXA4_HUMAN
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q00056
-
Expression Region
1-320aa
-
AA Sequence
MTMSSFLINS NYIEPKFPPF EEYAQHSGSG GADGGPGGGP GYQQPPAPPT QHLPLQQPQL PHAGGGREPT ASYYAPRTAR EPAYPAAALY PAHGAADTAY PYGYRGGASP GRPPQPEQPP AQAKGPAHGL HASHVLQPQL PPPLQPRAVP PAAPRRCEAA PATPGVPAGG SAPACPLLLA DKSPLGLKGK EPVVYPWMKK IHVSAVNPSY NGGEPKRSRT AYTRQQVLEL EKEFHFNRYL TRRRRIEIAH TLCLSERQVK IWFQNRRMKW KKDHKLPNTK MRSSNSASAS AGPPGKAQTQ SPHLHPHPHP STSTPVPSSI
-
Molecular Weight
34.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HOXA4, a member of the homeobox gene family, plays a crucial role in embryonic development and cell differentiation. It regulates various biological processes, including limb formation, hematopoiesis, and the development of specific structures in the vertebrate body plan. Given its importance in these developmental pathways, abnormal expression or mutations of HOXA4 have been implicated in several diseases, including cancers and congenital disorders. The study of recombinant HOXA4 protein helps elucidate its functional mechanisms and interactions with other proteins in signaling pathways. By producing and analyzing HOXA4 in a controlled laboratory setting, researchers aim to understand its role in developmental biology and its potential implications in regenerative medicine and therapeutic interventions for diseases associated with HOXA4 dysregulation. This exploration not only contributes to basic biological knowledge but also opens avenues for potential clinical applications, such as targeted therapies that could modulate HOXA4 activity in pathological conditions. Thus, research on HOXA4 recombinant protein serves as a vital bridge linking fundamental developmental processes to innovative medical solutions.
